Speakers

Expand/Collapse

Seth Feuerstein
Executive Director and Founder, Center for Digital Health and Innovation
Yale University School of Medicine

Day One

Wednesday, December 2 2020

2:45 pm | Panel Discussion - How to Work With Payer, Provider, and Pharma

Kim Baden-Kristensen
CEO & Co-Founder
Brain+

Day One

Wednesday, December 2 2020

2:45 pm | Panel Discussion - How to Work With Payer, Provider, and Pharma

Jennifer Lavanture
VP Business Development
MedRhythms

Day One

Wednesday, December 2 2020

2:00 pm | Panel Discussion – Creating Sustainable, Replicable Models of Reimbursement as a Matter of Priority to Move the Space Forward

Megan Coder
Executive Director
Digital Therapeutics Alliance

Day One

Wednesday, December 2 2020

9:00 am | Fireside Chat – Implications of FDA Guidance to Ease Regulatory Enforcement During COVID-19

Georgia Mitsi
Executive Director
Sunovian Pharmaceuticals

Day Two

Thursday, December 3 2020

10:30 am | Panel Discussion – The Buzz Words: Sustainability & Scalability

Tryggvi Thorgeirsson
CEO & Co-Founder
SidekickHealth

Day Two

Thursday, December 3 2020

11:15 am | Case Study - How Sidekick Collaborates with Pharma to Drive DTx Innovation

Danielle Fau
Advisor for Medical Device Technology & Innovation
FDA

Day One

Wednesday, December 2 2020

2:00 pm | Panel Discussion – Creating Sustainable, Replicable Models of Reimbursement as a Matter of Priority to Move the Space Forward

Austin Speier
Chief Strategy Officer
Click Therapeutics

Day One

Wednesday, December 2 2020

9:45 am | Panel Discussion - The Continued Rise of Digital Therapeutics Post COVID-19

Acacia Parks
Chief Science Officer
Happify

Day One

Wednesday, December 2 2020

9:00 am | Fireside Chat – Implications of FDA Guidance to Ease Regulatory Enforcement During COVID-19

Day Two

Thursday, December 3 2020

9:00 am | Understanding the Multiple Forms an FDA-Regulated Digital Therapeutic Can Take

Amir Lahav
Healthcare Intelligence and Digital Transformation Consultant
Mitsubishi Tanabe Pharma America

Day One

Wednesday, December 2 2020

4:15 pm | The Emergence of Patient-Centric DTx Solutions

Anand Iyer
Chief Strategy Officer
WellDoc

Day One

Wednesday, December 2 2020

12:20 pm | Fireside Chat – How to Unlock Health & Economic Outcomes Through DTx at Scale

12:00 pm | Accelerating Reimbursement During COVID-19 Response

9:45 am | Panel Discussion - The Continued Rise of Digital Therapeutics Post COVID-19

Andy Molnar
VP, Market Access
Cognoa

Day Two

Thursday, December 3 2020

10:30 am | Panel Discussion – The Buzz Words: Sustainability & Scalability

Anil Jina
Chief Medical Officer
Akili Interactive

Day One

Wednesday, December 2 2020

11:30 am | Case Study – Implementation of a Digital Therapeutic During a Pandemic

9:00 am | Fireside Chat – Implications of FDA Guidance to Ease Regulatory Enforcement During COVID-19

Brigitta Monz
Global Head Measurement Science, Digital Health Technologies
Roche

Day Two

Thursday, December 3 2020

10:30 am | Panel Discussion – The Buzz Words: Sustainability & Scalability

9:30 am | Digital Legislation in Germany – A Role Model for Others to Follow?

Chris Lento
Head of Healthcare Strategic Partnerships
Noom

Day Two

Thursday, December 3 2020

10:30 am | Panel Discussion – The Buzz Words: Sustainability & Scalability

Frank Baitman
Global Head of Compliance & Strategy, Digital Health Technologies, Personalized Healthcare Product Development
Genentech

Day One

Wednesday, December 2 2020

9:45 am | Panel Discussion - The Continued Rise of Digital Therapeutics Post COVID-19

Jin Lee
Director of Digital Health Product/Commercial Strategy
Astellas Pharma

Day One

Wednesday, December 2 2020

2:45 pm | Panel Discussion - How to Work With Payer, Provider, and Pharma

9:45 am | Panel Discussion - The Continued Rise of Digital Therapeutics Post COVID-19

Joris Van Dam
Head of Digital Therapeutics
Novartis

Day One

Wednesday, December 2 2020

9:45 am | Panel Discussion - The Continued Rise of Digital Therapeutics Post COVID-19

Kenneth Snow
Medical Director
CVS Health

Day One

Wednesday, December 2 2020

12:20 pm | Fireside Chat – How to Unlock Health & Economic Outcomes Through DTx at Scale

12:00 pm | Accelerating Reimbursement During COVID-19 Response

Laurel Sweeney
Principal
Access Strategies

Day One

Wednesday, December 2 2020

2:00 pm | Panel Discussion – Creating Sustainable, Replicable Models of Reimbursement as a Matter of Priority to Move the Space Forward

Lauren Li
Head of Digital Health
Ipsen

Day One

Wednesday, December 2 2020

2:00 pm | Panel Discussion – Creating Sustainable, Replicable Models of Reimbursement as a Matter of Priority to Move the Space Forward

Mark Yunger
Head of IT
Servier Pharmaceuticals

Day Two

Thursday, December 3 2020

1:45 pm | Case Study - Lessons Learned from First Year in Digital Therapeutics Development

Matthias Zenker
Senior Vice President & Head, Business Development DTx
GAIA AG

Day Two

Thursday, December 3 2020

10:30 am | Panel Discussion – The Buzz Words: Sustainability & Scalability

Melinda Decker
Chief Commercial Officer
Mymee

Day One

Wednesday, December 2 2020

2:00 pm | Panel Discussion – Creating Sustainable, Replicable Models of Reimbursement as a Matter of Priority to Move the Space Forward

Day Two

Thursday, December 3 2020

3:00 pm | Chair’s Closing Remarks

8:55 am | Chair’s Opening Remarks

Mette Dyhrberg
Founder & CEO
Mymee

Day One

Wednesday, December 2 2020

4:45 pm | Patient Fireside Chat - A Different Perspective

Owen McCarthy
President & CoFounder
MedRhythms

Day One

Wednesday, December 2 2020

8:50 am | Chair’s Opening Remarks

6:15 pm | Chair’s Closing Remarks

3:30 pm | Role of Evidence in DTx – Current Status and Case Studies

Pavan Choksi
Venture Partner
Arkitekt Ventures

Day Two

Thursday, December 3 2020

1:15 pm | We’re Past the Pioneering Phase, Now it’s Time to Commercialize

Saeju Jeong
Co-Founder & CEO
Noom

Day Two

Thursday, December 3 2020

11:45 am | Healthier Lives Through Behavior Change